| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/24/2000 | WO2000037470A8 Antihistaminic spiro compounds |
| 08/24/2000 | WO2000032205A8 Immunomodulatory methods using carbohydrate antigens |
| 08/24/2000 | WO2000022134A3 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO2000006194A3 Depletion of cells responsible for antibody-mediated graft rejection |
| 08/24/2000 | WO2000004917A9 USE OF HC gp-39 IN IMMUNE DISEASES |
| 08/24/2000 | WO1999040938A3 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 08/24/2000 | WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2368309A1 Peptide variants of the tumour marker muc1 and the use thereof |
| 08/24/2000 | CA2363670A1 Chemical compounds |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362306A1 Chemical compounds |
| 08/24/2000 | CA2362290A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2362136A1 High molecular weight extracts of convolvulus arvensis (field bindweed) |
| 08/24/2000 | CA2361273A1 Inhibitors for use in hemostasis and immune function |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029865A2 Process and intermediates for preparing 5-lipoxygenase inhibitors |
| 08/23/2000 | EP1029549A1 Formulation of nucleic acids and acemannan |
| 08/23/2000 | EP1029538A2 Soft gelatin capsule manufacture |
| 08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029043A1 Human receptor proteins; related reagents and methods |
| 08/23/2000 | EP1028974A1 Secreted proteins and polynucleotides encoding them |
| 08/23/2000 | EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists |
| 08/23/2000 | EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/23/2000 | EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 08/23/2000 | EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 08/23/2000 | EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents |
| 08/23/2000 | EP1028751A1 Methods and compositions comprising glycoprotein glycoforms |
| 08/23/2000 | EP1028738A1 Use of cytokines and mitogens to inhibit pathological immune responses |
| 08/23/2000 | EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 08/23/2000 | EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 08/23/2000 | EP0729473B1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 08/23/2000 | EP0674642B1 Pyrazolopyrimidines as crf antagonists |
| 08/23/2000 | CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
| 08/23/2000 | CN1264422A Immunity enhancing lactic acid bacteria |
| 08/23/2000 | CN1264382A Novel compounds |
| 08/23/2000 | CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 08/23/2000 | CN1264377A Substituted pyrazoles as P38 kinase inhabitors |
| 08/23/2000 | CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors |
| 08/23/2000 | CN1264304A Lipid-based immune modulator composition |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/23/2000 | CN1055697C Phospholipi derivatives containing higher elements of the Vth main group |
| 08/23/2000 | CN1055639C Health-care medicine |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6107334 Dietary control of arachidonic acid metabolism |
| 08/22/2000 | US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 08/22/2000 | US6107327 Therapeutic treatment for HIV infection |
| 08/22/2000 | US6107305 Antiproferative agent, antiinflammatory agents |
| 08/22/2000 | US6107300 Arylamino fused pyrimidines |
| 08/22/2000 | US6107294 Nervous system and psychological disorders |
| 08/22/2000 | US6107291 Antiinflammatory agent |
| 08/22/2000 | US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 08/22/2000 | US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics |
| 08/22/2000 | US6106867 Gelatinized propolis food products |
| 08/22/2000 | US6106858 Loading active materials of liposomes by dissolving |
| 08/22/2000 | US6106844 Administering to venom allergic patient |
| 08/22/2000 | US6106841 Delivery method for recombinant raccoon poxvirus |
| 08/22/2000 | US6106840 Autoimmune diseases |
| 08/22/2000 | US6106834 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation |
| 08/22/2000 | US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium |
| 08/22/2000 | CA2187409C Stable crystalline tetrahydrofolic acid salts |
| 08/17/2000 | WO2000047713A2 Genes encoding the 5h7 antibody and methods for conferring programmed cell death properties to cells |
| 08/17/2000 | WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/17/2000 | WO2000047620A1 Cytokine-binding domain |
| 08/17/2000 | WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation |
| 08/17/2000 | WO2000047610A2 Method for altering undesirable immune responses to polypeptides |
| 08/17/2000 | WO2000047607A1 A synthetic peptide disturbing intracellular signaling |
| 08/17/2000 | WO2000047603A2 16-hydroxyestratrienes as selective estrogens |
| 08/17/2000 | WO2000047602A1 33 human secreted proteins |
| 08/17/2000 | WO2000047601A1 Shortened-chain polynucleotides and process for the preparation thereof |
| 08/17/2000 | WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/17/2000 | WO2000047580A2 Phenyl urea and phenyl thiourea derivatives |
| 08/17/2000 | WO2000047575A1 Pyrrole derivatives and cell death inhibitors |
| 08/17/2000 | WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/17/2000 | WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 08/17/2000 | WO2000047559A2 5-ht1f agonists |
| 08/17/2000 | WO2000047558A1 Amide compounds and medicinal use thereof |
| 08/17/2000 | WO2000047231A2 Novel antisense inhibition of rad51 |
| 08/17/2000 | WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
| 08/17/2000 | WO2000047216A1 Immunogenic compositions for use as vaccines |
| 08/17/2000 | WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors |
| 08/17/2000 | WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 08/17/2000 | WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 08/17/2000 | WO2000033870A3 New cancer treatments |
| 08/17/2000 | WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/17/2000 | WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 08/17/2000 | WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein |
| 08/17/2000 | WO2000015231A9 Adenosine a3 receptor modulators |
| 08/17/2000 | WO2000014262A9 Methylation of plasmid vectors |
| 08/17/2000 | WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |